论文部分内容阅读
The title compound, 5-methoxy-butyrolacto[3,4-b]-1-N-cyclohexylaziridine 1, has been synthesized via tandem Micheal addition and intramolecular nucleophilic substitution reactions of 5-methoxy-3-bromo-2(5H)-furanones 4 with primary amines 5, and structurally determined by single-crystal X-ray diffraction. Crystal data: C11H17NO3, Mr = 211.26, monoclinic system, space group P21/c, a = 17.800(3), b = 5.3864(10), c = 12.2571(10) ?, β = 90.449(3)°, V = 1175.1(3) ?3, Z = 4, Dc = 1.194 g/cm3, λ(MoKα) = 0.071073 nm, μ = 0.087 mm～1 and F(000) = 456. The structure was refined to R = 0.0505 and wR = 0.1208 for 2579 observed reflections (I > 2σ(I)). The crystallographic results of molecule 1 show that the functionalized aziridine ring is fused with a lactone ring to form the component with [3.1.0] bicyclic skeleton.
The title compound, 5-methoxy-butyrolacto [3,4-b] -1-N-cyclohexylaziridine 1, has been synthesized via tandem Micheal addition and intramolecular nucleophilic substitution reactions of 5-methoxy-3-bromo- Crystal data: C11H17NO3, Mr = 211.26, monoclinic system, space group P21 / c, a = 17.800 (3), b = 5.3864 (10) , C = 12.2571 (10) ?,? = 90.449 (3) °, V = 1175.1 (3)? 3, Z = 4 and Dc = 1.194 g / cm3 and? MoKα = 0.071073 nm and μ = 1 and F (000) = 456. The structure was refined to R = 0.0505 and wR = 0.1208 for 2579 observed reflections (I> 2σ (I)). The crystallographic results of molecule 1 show that the functionalized aziridine ring is fused with a lactone ring to form the component with [3.1.0] bicyclic skeleton.